# Development of Non-Opioid Analgesics for Acute Pain – FDA Guidance

Source: https://www.keypedia.com/guidances/guidance-document/development-of-non-opioid-analgesics-for-acute-pain/3128d3e1-20cf-4358-a5d7-d12eebd721c0

> FDA guidance document: Development of Non-Opioid Analgesics for Acute Pain. Issue date: May 13, 2026. Get complete insights and analysis.

---

## Details

- Title: Development of Non-Opioid Analgesics for Acute Pain
- Communication Type: Guidance Document
- Product Type: drugs
- Office Name: Center for Drug Evaluation and Research
- Office URL: /offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c
- Issue Date: 2026-05-13
- Last Changed: 2026-05-13
- Docket Number: <a href="https://www.regulations.gov/docket/FDA-2021-N-0556">FDA-2021-N-0556</a>

## Related Documents

- [Development of Non-Opioid Analgesics for Chronic Pain](https://www.keypedia.com/guidances/guidance-document/development-of-non-opioid-analgesics-for-chronic-pain/35ce2386-2566-4997-9c26-93a1b380a910)
- [Monoclonal Antibodies: Streamlined Nonclinical Safety Studies: Draft Guidance for Industry](https://www.keypedia.com/guidances/guidance-document/monoclonal-antibodies-streamlined-nonclinical-safety-studies-draft-guidance-for-industry/439cec36-0e7d-4c02-88e4-7a0af7b47fa4)
- [Gastroparesis: Clinical Evaluation of Drugs for Treatment Guidance for Industry](https://www.keypedia.com/guidances/guidance-document/gastroparesis-clinical-evaluation-of-drugs-for-treatment-guidance-for-industry/4b7bc445-8e11-4ce8-a6d6-3439f06daab5)